Lupin today announced that it has received approval from the United States Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA Meclizine Hydrochloride Tablets USP 125 mg 25 mg and 50 mg to market a generic equivalent of Antivert Tablets 125 mg 25 mg and 50 mg of Casper Pharma LLC The product will be manufactured at Lupins facility in Goa India Meclizine Hydrochloride Tablets RLD Antivert had estimated annual sales of USD 29 million in the US IQVIA MAT June 2022
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
